Silver Book Fact

A study looking at the effects of cardiovascular medicines in elderly patients who had previous heart attacks, found a total death rate reduction of 24% between 1995 and 2004.

Setoguchi, Soko, Robert J. Glynn, Jerry Avorn, Murray A. Mittleman, Raisa Levin, and Wolfgang C. Winkelmayer. Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis. JACC. 2008; 51(13): 1247-54. http://content.onlinejacc.org/cgi/content/abstract/51/13/1247?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Setoguchi&fulltext=Improvements+in+long-term+mortality&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HW

Reference

Title
Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis
Publication
JACC
Publication Date
2008
Authors
Setoguchi, Soko, Robert J. Glynn, Jerry Avorn, Murray A. Mittleman, Raisa Levin, and Wolfgang C. Winkelmayer
Volume & Issue
Volume 51, Issue 13
Pages
1247-54
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • A major objective is to control blood pressure and preempt primary and secondary stroke. Assessing specific antihypertensive therapies will identify specific treatments that will lower blood pressure.  
  • Glycoprotein inhibitors have been shown to reduce the risk of death, a second heart attack, or the need for revascularization by 48% to 52% in patients who have suffered a…  
  • Lowering blood pressure associated with reduction in stroke risk
    Lowering of blood pressure is associated with a 30% to 40% reduction in stroke risk.  
  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…